Elliptic Laboratories (Norway) Performance
| ELABS Stock | NOK 13.04 0.10 0.76% |
On a scale of 0 to 100, Elliptic Laboratories holds a performance score of 12. The firm shows a Beta (market volatility) of 0.94, which means possible diversification benefits within a given portfolio. Elliptic Laboratories returns are very sensitive to returns on the market. As the market goes up or down, Elliptic Laboratories is expected to follow. Please check Elliptic Laboratories' downside variance, and the relationship between the sortino ratio and accumulation distribution , to make a quick decision on whether Elliptic Laboratories' price patterns will revert.
Risk-Adjusted Performance
Good
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Elliptic Laboratories AS are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of very weak basic indicators, Elliptic Laboratories displayed solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 99.7 M | |
| Total Cashflows From Investing Activities | -17.6 M |
Elliptic |
Elliptic Laboratories Relative Risk vs. Return Landscape
If you would invest 960.00 in Elliptic Laboratories AS on April 28, 2025 and sell it today you would earn a total of 344.00 from holding Elliptic Laboratories AS or generate 35.83% return on investment over 90 days. Elliptic Laboratories AS is generating 0.5506% of daily returns and assumes 3.5897% volatility on return distribution over the 90 days horizon. Simply put, 32% of stocks are less volatile than Elliptic, and 89% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Elliptic Laboratories Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Elliptic Laboratories' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Elliptic Laboratories AS, and traders can use it to determine the average amount a Elliptic Laboratories' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1534
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ELABS | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.59 actual daily | 32 68% of assets are more volatile |
Expected Return
| 0.55 actual daily | 11 89% of assets have higher returns |
Risk-Adjusted Return
| 0.15 actual daily | 12 88% of assets perform better |
Based on monthly moving average Elliptic Laboratories is performing at about 12% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Elliptic Laboratories by adding it to a well-diversified portfolio.
Elliptic Laboratories Fundamentals Growth
Elliptic Stock prices reflect investors' perceptions of the future prospects and financial health of Elliptic Laboratories, and Elliptic Laboratories fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Elliptic Stock performance.
| Return On Equity | -0.0289 | |||
| Return On Asset | -0.0328 | |||
| Profit Margin | (0.12) % | |||
| Operating Margin | (0.24) % | |||
| Current Valuation | 2 B | |||
| Shares Outstanding | 104.07 M | |||
| Price To Book | 6.39 X | |||
| Price To Sales | 27.21 X | |||
| Revenue | 54.6 M | |||
| EBITDA | (3.58 M) | |||
| Cash And Equivalents | 216.83 M | |||
| Cash Per Share | 9.94 X | |||
| Total Debt | 10.53 M | |||
| Debt To Equity | 0.12 % | |||
| Book Value Per Share | 3.29 X | |||
| Cash Flow From Operations | (10.82 M) | |||
| Earnings Per Share | (0.17) X | |||
| Total Asset | 371.36 M | |||
About Elliptic Laboratories Performance
By examining Elliptic Laboratories' fundamental ratios, stakeholders can obtain critical insights into Elliptic Laboratories' financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Elliptic Laboratories is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
Elliptic Laboratories AS provides software-based artificial intelligence virtual smart sensors in Norway, China, South Korea, the United States, and Japan. The company was founded in 2006 and is based in Oslo, Norway. ELLIPTIC LABORATOR is traded on Oslo Stock Exchange in Norway.Things to note about Elliptic Laboratories performance evaluation
Checking the ongoing alerts about Elliptic Laboratories for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Elliptic Laboratories help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Elliptic Laboratories appears to be risky and price may revert if volatility continues | |
| Elliptic Laboratories has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 54.6 M. Net Loss for the year was (13.09 M) with profit before overhead, payroll, taxes, and interest of 3.79 M. | |
| Elliptic Laboratories AS has accumulated about 216.83 M in cash with (10.82 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 9.94. | |
| Roughly 31.0% of the company shares are held by company insiders |
- Analyzing Elliptic Laboratories' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Elliptic Laboratories' stock is overvalued or undervalued compared to its peers.
- Examining Elliptic Laboratories' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Elliptic Laboratories' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Elliptic Laboratories' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Elliptic Laboratories' stock. These opinions can provide insight into Elliptic Laboratories' potential for growth and whether the stock is currently undervalued or overvalued.
Other Information on Investing in Elliptic Stock
Elliptic Laboratories financial ratios help investors to determine whether Elliptic Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Elliptic with respect to the benefits of owning Elliptic Laboratories security.